Attention Long-Term Shareholders of Cogent Communications Holdings, Inc. (NASDAQ: CCOI); Primoris Services Corporation (NYSE: PRIM); PROCEPT BioRobotics Corporation (NASDAQ: PRCT); and Roblox Corporation (NYSE: RBLX): Grabar Law Office is Investigating…

PHILADELPHIA, Aug. 18, 2026 (GLOBE NEWSWIRE) --

Cogent Communications Holdings, Inc. (NASDAQ: CCOI):

Grabar Law Office is investigating claims on behalf of shareholders of Cogent Communications Holdings, Inc. (NASDAQ: CCOI).

What is This Investigation About? The investigation concerns whether certain officers and directors breached the fiduciary duties they owed to the company.

If you purchased Cogent Communications Holdings, Inc. (NASDAQ: CCOI) shares before February 29, 2024, and still hold shares today, you can seek corporate reforms, the return of funds back to the company, and a court approved incentive award at no cost to you whatsoever. Please visit https://grabarlaw.com/the-latest/ccoi-shareholder-investigation/, contact Joshua Grabar at jgrabar@grabarlaw.com, or call 267-507-6085.

What is Alleged? As alleged in a recently filed securities fraud class action Complaint, Cogent Communications Holdings, Inc. (NASDAQ: CCOI), through certain of its officers, made materially false and misleading statements and/or failed to disclose materially adverse facts pertaining to Cogent’s business, operations, and financial condition, which were known to or recklessly disregarded by defendants including: (i) that the vast majority of the purported orders in Cogent’s optical wavelength “backlog” were unlikely to ever result in a paid order; (ii) that large quantities of the customers in Cogent’s purported optical wavelength “backlog” were unable or unwilling to accept delivery even if Cogent was in a position to provision the wavelength in a timely manner; (iii) that, as a result of (i)-(ii) above, defendants had materially misrepresented customer demand for Cogent’s optical wavelength services and the nature of Cogent’s purported “backlog” of wavelength orders; (iv) that, as a result of (i)-(iii) above, Cogent was not on track to achieve its revenue and margin targets and such targets lacked a reasonable basis in objective fact; (v) that Cogent did not have the financial capacity or business fundamentals to maintain its long-standing dividend policy; and (vi) that there was a material, undisclosed risk that defendant David Schaeffer would be forced to sell vast quantities of Cogent stock as a result of his high-risk pledging activities, thereby further depressing the price of Cogent stock in the event the truth regarding Cogent’s “backlog,” demand issues, and financial position were ever revealed.

What Can You Do Now? If you purchased Cogent Communications Holdings, Inc. (NASDAQ: CCOI) shares before February 29, 2024, and still hold shares today, you are encouraged to visit https://grabarlaw.com/the-latest/ccoi-shareholder-investigation/, contact Joshua Grabar at jgrabar@grabarlaw.com, or call 267-507-6085. You can seek corporate reforms, the return of funds back to the company, and a court approved incentive award at no cost to you whatsoever.   #CCOI #CogentCommunications $CCOI

Primoris Services Corporation (NYSE: PRIM):

Grabar Law Office is investigating claims on behalf of shareholders of Primoris Services Corporation (NYSE: PRIM).

What is The Investigation About? The investigation concerns whether certain officers and directors breached the fiduciary duties they owed to the company.

If you purchased Primoris Services Corporation (NYSE: PRIM) shares before August 5, 2025, and still hold shares today, you can seek corporate reforms, the return of funds back to the company, and a court approved incentive award at no cost to you whatsoever through a shareholder governance action. Please visit https://grabarlaw.com/the-latest/primoris-shareholder-investigation/, contact Joshua Grabar at jgrabar@grabarlaw.com, or call 267-507-6085.  

What is Being Alleged? As alleged in a recently filed securities fraud class action Complaint, Primoris Services Corporation (NYSE: PRIM), through certain of its officers, made materially false and misleading statements and/or failed to disclose that (i) Primoris’ cost estimation, cost-to-complete forecasting, and project oversight processes were deficient and failed to provide reliable estimates of the costs and expected profitability of significant fixed-price renewable energy projects; (ii) as a result, Primoris systematically underestimated the costs and risks of significant fixed-price renewable energy projects that were experiencing material cost overruns, execution problems, and schedule delays; and (iii) accordingly, defendants’ statements regarding Primoris’ estimating processes, project execution, ability to manage project risk, financial performance, and financial guidance lacked a reasonable basis and omitted material adverse facts when made.

What Can You Do Now? If you purchased Primoris Services Corporation (NYSE: PRIM) shares before August 5, 2025, and still hold shares today, you are encouraged to visit https://grabarlaw.com/the-latest/primoris-shareholder-investigation/, contact Joshua Grabar at jgrabar@grabarlaw.com, or call 267-507-6085. You can seek corporate reforms, the return of funds back to the company, and a court approved incentive award at no cost to you whatsoever.   #PRIM #Primoris $PRIM

PROCEPT BioRobotics Corporation (NASDAQ: PRCT):

Grabar Law Office is investigating claims on behalf of shareholders of PROCEPT BioRobotics Corporation (NASDAQ: PRCT).

What is This Investigation About? The investigation concerns whether certain officers and directors breached the fiduciary duties they owed to the company.

If you purchased PROCEPT BioRobotics Corporation (NASDAQ: PRCT) shares before February 28, 2024, and still hold shares today, you can seek corporate reforms, the return of funds back to the company, and a court approved incentive award at no cost to you whatsoever. Please visit https://grabarlaw.com/the-latest/procept-shareholder-investigation/, contact Joshua Grabar at jgrabar@grabarlaw.com, or call 267-507-6085.

What is Alleged? As alleged in a recently filed securities fraud class action PROCEPT BioRobotics Corporation (NASDAQ: PRCT), through certain of its officers, made materially false and misleading statements and/or failed to disclose materially adverse facts including: (i) that Procept had utilized an extensive discount program designed to incentivize its customers to place bulk orders in excess of procedure demand; (ii) that Procept’s undisclosed discount program had artificially and unsustainably inflated Procept’s reported U.S. handpiece unit sales and revenues by pulling forward sales at the expense of future periods; (iii) that Procept’s undisclosed discount program had caused customer handpiece orders to materially exceed underlying procedure demand throughout the Class Period and that this differential had materially grown over time; (iv) that Procept’s consistent surplus of U.S. handpiece unit sales relative to performed procedures had created a glut of field inventory and overstocking amongst Procept’s customer base, amounting to more than 10,000 excess units by the end of the Class Period; (v) that, as a result of (i)-(iv) above, defendants’ representations regarding Procept’s handpiece unit sales and the utilization of Procept’s field Systems were materially overstated; (vi) that, as a result of (i)-(v) above, Procept was acutely exposed to material undisclosed risks of significant operational and financial harm; and (vii) that, as a result of (i)-(vi) above, Procept was unable to achieve its stated 2025 handpiece sales and revenue guidance and such guidance lacked a reasonably achievable factual basis.

What Can You Do Now? If you purchased PROCEPT BioRobotics Corporation (NASDAQ: PRCT) shares before February 28, 2024, and still hold shares today, you are encouraged to visit https://grabarlaw.com/the-latest/procept-shareholder-investigation/, contact Joshua Grabar at jgrabar@grabarlaw.com, or call 267-507-6085. You can seek corporate reforms, the return of funds back to the company, and a court approved incentive award at no cost to you whatsoever. #Procept #PRCT $PRCT

Roblox Corporation (NYSE: RBLX):

WHAT IS HAPPENING? Grabar Law Office is investigating claims on behalf of shareholders of Roblox Corporation (NYSE: RBLX). The investigation concerns whether certain officers and directors breached the fiduciary duties they owed to the company.

If you purchased Roblox Corporation (NYSE: RBLX), shares prior to October 31, 2024, and still hold shares today, you can seek corporate reforms, the return of funds back to the company, and a court approved incentive award at no cost to you whatsoever. Please visit https://grabarlaw.com/the-latest/roblox-shareholder-investigation/, contact Joshua Grabar at jgrabar@grabarlaw.com, or call 267-507-6085.

WHY? A recently filed securities fraud class action complaint alleges that Roblox Corporation (NYSE: RBLX) via certain of its officers, made material misrepresentations to investors concerning Roblox’s anticipated earnings growth. Specifically, Roblox stated that 2026 bookings would grow by 22% to 26%, which reflected Roblox’s “confidence in the adoption of our age-checking technology.” Roblox also stated that its age verification features provided “a bigger growth opportunity in the 18-plus demographic than previously assumed” and stated that its “18 and over cohort is growing at over 50%[.]” In truth, as alleged, Roblox’s age verification rollout was causing a slowdown in on-platform communication, app store rating reductions, and a considerable reduction in organic growth.

WHAT CAN DO NOW? If you purchased Roblox Corporation (NYSE: RBLX) shares prior to October 31, 2024, and still hold shares today, you are encouraged to visit https://grabarlaw.com/the-latest/roblox-shareholder-investigation/, contact Joshua Grabar at jgrabar@grabarlaw.com, or call 267-507-6085. You can seek corporate reforms, the return of funds back to the company, and a court approved incentive award at no cost to you whatsoever. #Roblox #RBLX $RBLX

Attorney Advertising Disclaimer

Contact:
Joshua H. Grabar, Esq.
Grabar Law Office
One Liberty Place
1650 Market Street, Suite 3600
Philadelphia, PA 19103
Tel:  267-507-6085
Email: jgrabar@grabarlaw.com